Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $237 | $292 | $392 | $370 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $4 | $32 | $3 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $65 | $63 | $9 | $5 |
| Total Curr. Assets | $306 | $387 | $403 | $379 |
| Property Plant & Equip (Net) | $36 | $41 | $45 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $2 | $0 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $0 | $2 | $2 |
| Total NC Assets | $38 | $43 | $47 | $14 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $344 | $429 | $450 | $393 |
| Liabilities | – | – | – | – |
| Payables | $7 | $5 | $7 | $10 |
| Short-Term Debt | $4 | $4 | $65 | $24 |
| Tax Payable | $0 | $1 | $1 | $0 |
| Deferred Revenue | $22 | $47 | $36 | $0 |
| Other Curr. Liab. | $33 | $24 | $18 | $65 |
| Total Curr. Liab. | $65 | $82 | $127 | $100 |
| LT Debt | $25 | $26 | $30 | $45 |
| Deferred Rev, NC | $13 | $42 | $20 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $3 | $20 |
| Total NC Liab. | $38 | $69 | $53 | $65 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $29 | $30 | $34 | $6 |
| Total Liabilities | $103 | $151 | $180 | $165 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$449 | -$368 | -$338 | -$347 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $690 | $646 | $608 | $576 |
| Total Equity | $241 | $279 | $270 | $228 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $344 | $429 | $450 | $393 |
| Net Debt | -$208 | -$262 | -$297 | -$301 |